Bulk Drug Manufacturing

Ajanta Pharma to set up formulations unit in Dahej and Savili

2013-02-28T16:34:28+00:00

Ajanta Pharma is setting up new formulations plant in Dahej SEZ and Savli in Vadodara district of Gujarat with an investment of Rs.4000 million. The company will start work by Feb 2013 and will complete the same by 2014-15. Besides this, the company operates 4 manufacturing unit across India and one in Marutius. Ajanta is currently present in therapeutic areas of anti- malarial, cardiology, dermatology, gastroenterology, musculoskeletal, ophthalmology and respiratory.

Panacea Biotec commissions Baddi plant

2012-05-23T07:32:22+00:00

Panacea Biotec had commissioned a new manufacturing facility at Baddi in Himachal Pradesh with an investment of Rs. 550 million. It will manufacture anti cancer formulations and will have a capacity of 1.2 million vials. It will cater to export markets of USA, where there is a rising demand for oncology products. Currently, the company caters to the market from its Navi Mumbai plant.

Lupin Pharmaceuticals to set up new formulations plant in MHIAN SEZ

2012-05-23T07:30:55+00:00

Lupin Pharmaceuticals is setting up a new formulation manufacturing facility in Multi modal International Cargo Hub and Airport (MHIAN) SEZ in Nagpur. The project cost is estimated at Rs. 4000 million and will produce new formulations for export to US, Japan and Europe. The project will go operational in 2013.

Lincoln Pharma plans expansion at Khatraj unit

2011-09-20T15:28:05+00:00

Project Location : Khatraj, Gujarat

Lincoln Pharma is planning an expansion at its existing Khatraj plant near Ahmedabad with an investment of Rs. 300 million. The company is scrapping its old plant which was built in 1979 to build a modern plant for regulated markets. It will produce injectables, ampoules, vials, dry powders, ointments. The capacity of the new unit will 30 million units. The project is likely to go operational by December 2011. The company is also setting up a new facility at Nandasan in Mehesana district of Gujarat with an investment of Rs. 600 million. The plant would be built according to the requirements of the regulated markets of the US and Europe and will manufacture solid doses

Granules India plans expansion of API at Vizag

2011-09-20T15:27:36+00:00

Project Location : Vizag, Andhra Pradesh

Project Capacity : 20000 tpa

Granules India is planning to set up a new manufacturing facility for active pharmaceutical ingredients (API) in Vizag in Andhra Pradesh. It will be a greenfield project near its existing facility with a capacity of 20,000 tonnes. The investment programme is estimated at Rs. 800 million which will be raised from internal accruals and debts

Astra Zeneca plans expansion of its tablet plant in Bangalore

2010-06-01T09:43:05+00:00

Astra Zeneca’s board has approved its expansion of its tablet plant in Bangalore. The total project cost is estimated at Rs. 700 million. Its existing plant which is in operation since 1981 is WHO GMP certified and tablets are currently exported to South East Asian nations.

Eisai Pharma to commence commercial operations at Visakhapatnam unit in Sept 2010

2010-01-31T15:21:34+00:00

Eisai Pharmatechnology and Manufacturing India Private Ltd, a Japanese group company is planning to commence commercial operations of its Visakhapatnam unit by Sept 2010. The company had invested around Rs. 2500 million which had come up in Pharma Special City SEZ. The facility comprises of pilot plant, active pharmaceutical ingredients (API) unit, formulations manufacturing unit and a research lab. The unit will have a capacity of 2 billion tablet per year and 30 tonne of formulations. Its capacity may be doubled later.

Suncare Formulations to set up formulations unit at Selaqui

2009-06-09T07:09:01+00:00

Suncare Formulations to set up formulations unit at Selaqui in Dehradun in Uttarkhand with an investment of Rs. 50 million. The project involves setting up of the plant with the following capacity

i. Tablets-25 lac/day (existing 5.0 lakhs/day)

ii. Capsule-5 lac/day (existing same)

iii. Liquid-0.4 lac/day(existing 0.20 lakhs)

iv. Ointments-0.20 lac/day(existing same)

v. Powder-0.50 lac/day(existing nil)

Elder Pharmaceuticals to expand its pharma unit at Langha

2009-06-09T07:06:42+00:00

Elder Pharmaceuticals to expand its pharma unit at Langha in Charba in Dehradun in Uttarkhand with an investment of Rs. 500 million. The new unit will manufacture the following products

S.No.	Name of Products	Quantity
1	Liquid Injectables	110 lacs ampoules/months
2	Dry powder injection Cephalosporin	24 lacs/month
3	Cephalosporin Capsules	65 lacs/month
4	Cephalosporin	30 lacs/month
5	Oral Liquids & Syrups,	30 lacs/month
6	Soft Gelatin Capsules	300 lacs/month